In our organization we are struggling with Medication reconciliation compliance in outpatient. We have manual system for recording current/ past medications by the physician in patient medical record and also have manual prescriptions. As a result this Med Rec information is not available to pharmacist at outpatient pharmacy. I would want to know from the organization who have handled similar challenge. In Joint commission Intl. 07th edition its given much focus.

What tactics are you using at your site to ensure that the full dose of intermittent IVPBs (i.e antibiotics, chemotherapy, etc) is being receive by patients when using medication pumps? At my site, 23ml of medication is left in the tubing once the dose has stopped running – if run as a primary infusion. We haven’t found a perfect solution in getting the remaining amount to the patient and would like to know what others have found to be successful solutions at their sites. Please also include the pump manufacturer that you use if you reply.

Is anyone diluting another strength of chlorhexidine gluconate to 0.05% for orthopedic irrigations?

Interested in how others track chemotherapy lifetime doses.

Does your pharmacy track cumulative doses for patients? If no, who is responsible for tracking? Is tracking a manual process for you or is this automated through your EHR? How do you accurately monitor cumulative doses when all doses are not given at a single facility?

I appreciate any insight that you can share!

Hello All,

I am wondering if anyone knows of any articles, MSOS or ISMP recommendations that explicitly state what should be included in IV Administration Guidelines (i.e. monitoring parameters, dilution for push meds, 'special circumstances').
All input would be appreciated.

Karen Haynes PharmD
Clinical Lead Pharmacist
Winchester Hospital
karensue.haynes@lahey.org

Does anyone have a formal policy or procedure for appropriate actions to take when a TPN becomes disconnected? Our formal stance is to not disconnect the line at all if possible. If something happens to interrupt the line we typically advise not to re-connect a TPN due to infectious risk but I haven't been able to find any great resources to back up this recommendation.

can we keep waste bin made of plastic inside the Verical Laminar Flow Hood to put extra fluid inside the waste bin to diminish hand movement outside of VLFH

Below are the links to two of the items discussed during today's MSOS Briefing webinar:

The Medication Safety Minute flipbook: http://online.fliphtml5.com/hktg/ivgg/

The International Medication Safety Network: https://www.intmedsafe.net/

APNO is a recommended therapy by various breastfeeding organizations for breastfeeding moms to apply to the nipples after feedings. The ingredients are miconazole, betamethasone, and mupirocin.

I was unable to find safety data for possible exposure of the neonate/infant. My biggest concern is for oral absorption of topical betamethasone by the baby.

Our hospital has been compounding this for use in our patients, but I have some concerns given there isn't any true evidence of efficacy or safety.

I would appreciate any help or insight on this. Thank you.

Dear colleagues,
I would like to know the process for adding a new medication on the formulary. Especially when a decision is required to select 01 brand among multiple brands available for a generic. whats the criteria for selection? who is the decision maker; the pharmacy or a Purchase dept.?

If you could share your formulary addition policy that would be of great help.

thanks,
Saharish